Oct 29, 2020 / 02:00PM GMT
Jenene D. Thomas - Jenene Thomas Communications, LLC - CEO
Good morning and thank you for joining us for the virtual investor KOL roundtable. My name is Jenene Thomas, CEO of JTC, and I will be the moderator for today's event.
For the lineup and schedule of today's presenting companies for the KOL roundtable event, visit www.virtualinvestorco.com. All the roundtables being held October 27 through 29 will have a video webcast replay available on this website as well as each presenting company's sites.
For our first roundtable of the day, I'm pleased to be joined by the Outlook Therapeutics management team, Lawrence Kenyon, President, CEO and CFO; Terry Dagnon, Chief Operating Officer; and Jeff Evanson, Chief Commercial Officer. We are also joined by Dr. Firas Rahhal, Partner at Retina Vitreous Associates Medical Group in Los Angeles and Associate Clinical Professor of Ophthalmology at the UCLA School of Medicine.
Thank you all for joining us today.
Lawrence A. Kenyon - Outlook
Outlook Therapeutics Inc at JTC Virtual Investor KOL Roundtable Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot